432 related articles for article (PubMed ID: 23497761)
21. Oral transmucosal fentanyl citrate for cancer breakthrough pain: a review.
Gordon DB
Oncol Nurs Forum; 2006 Nov; 33(2):257-64. PubMed ID: 16518441
[TBL] [Abstract][Full Text] [Related]
22. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR).
Coluzzi PH; Schwartzberg L; Conroy JD; Charapata S; Gay M; Busch MA; Chavez J; Ashley J; Lebo D; McCracken M; Portenoy RK
Pain; 2001 Mar; 91(1-2):123-30. PubMed ID: 11240084
[TBL] [Abstract][Full Text] [Related]
23. Multiple dose pharmacokinetics of oral transmucosal fentanyl citrate in healthy volunteers.
Egan TD; Sharma A; Ashburn MA; Kievit J; Pace NL; Streisand JB
Anesthesiology; 2000 Mar; 92(3):665-73. PubMed ID: 10719944
[TBL] [Abstract][Full Text] [Related]
24. A randomized clinical trial of oral transmucosal fentanyl citrate versus intravenous morphine sulfate for initial control of pain in children with extremity injuries.
Mahar PJ; Rana JA; Kennedy CS; Christopher NC
Pediatr Emerg Care; 2007 Aug; 23(8):544-8. PubMed ID: 17726413
[TBL] [Abstract][Full Text] [Related]
25. Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain.
Christie JM; Simmonds M; Patt R; Coluzzi P; Busch MA; Nordbrock E; Portenoy RK
J Clin Oncol; 1998 Oct; 16(10):3238-45. PubMed ID: 9779697
[TBL] [Abstract][Full Text] [Related]
26. Impact of allergic rhinitis and its treatment on the pharmacokinetics of nasally administered fentanyl.
Perelman M; Fisher AN; Smith A; Knight A
Int J Clin Pharmacol Ther; 2013 May; 51(5):349-56. PubMed ID: 23458227
[TBL] [Abstract][Full Text] [Related]
27. Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients.
Farrar JT; Cleary J; Rauck R; Busch M; Nordbrock E
J Natl Cancer Inst; 1998 Apr; 90(8):611-6. PubMed ID: 9554444
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of oral transmucosal fentanyl citrate for prehospital pain control on the battlefield.
Wedmore IS; Kotwal RS; McManus JG; Pennardt A; Talbot TS; Fowler M; McGhee L
J Trauma Acute Care Surg; 2012 Dec; 73(6 Suppl 5):S490-5. PubMed ID: 23192075
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and safety of fentanyl sublingual spray and fentanyl citrate intravenous: a single ascending dose study in opioid-naïve healthy volunteers.
Rauck R; Oh DA; Parikh N; Koch C; Singla N; Yu J; Nalamachu S; Vetticaden S
Curr Med Res Opin; 2017 Nov; 33(11):1915-1920. PubMed ID: 28681626
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery.
Foster D; Upton R; Christrup L; Popper L
Ann Pharmacother; 2008 Oct; 42(10):1380-7. PubMed ID: 18728103
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of fentanyl buccal tablet: a pooled analysis and review.
Darwish M; Xie F
Pain Pract; 2012 Apr; 12(4):307-14. PubMed ID: 21831253
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and safety of fentanyl sublingual spray and fentanyl citrate intravenous: a multiple ascending dose study in opioid-naïve healthy volunteers.
Rauck RL; Oh DA; Singla N; Koch C; Parikh N; Nalamachu S; Wilson D; Yu J; Vetticaden S
Curr Med Res Opin; 2017 Nov; 33(11):1921-1933. PubMed ID: 28942715
[TBL] [Abstract][Full Text] [Related]
33. Effect of Modulated Electrohyperthermia on the Pharmacokinetics of Oral Transmucosal Fentanyl Citrate in Healthy Volunteers.
Lee SY; Kim MG
Clin Ther; 2016 Dec; 38(12):2548-2554. PubMed ID: 27866658
[TBL] [Abstract][Full Text] [Related]
34. Oral transmucosal fentanyl citrate for the treatment of migraine headache pain in outpatients: a case series.
Landy SH
Headache; 2004 Sep; 44(8):762-6. PubMed ID: 15330821
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
[TBL] [Abstract][Full Text] [Related]
36. [Oral transmucosal fentanyl citrate (OTFC) in the treatment of breakthrough pain].
Borgbjerg FM; Rosenberg J
Ugeskr Laeger; 2000 Sep; 162(39):5237-40. PubMed ID: 11043058
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the single- and multiple-dose pharmacokinetics of fentanyl buccal soluble film in normal healthy volunteers.
Vasisht N; Gever LN; Tagarro I; Finn AL
J Clin Pharmacol; 2010 Jul; 50(7):785-91. PubMed ID: 20150521
[TBL] [Abstract][Full Text] [Related]
38. Relative oral bioavailability of morphine and naltrexone derived from crushed morphine sulfate and naltrexone hydrochloride extended-release capsules versus intact product and versus naltrexone solution: a single-dose, randomized-sequence, open-label, three-way crossover trial in healthy volunteers.
Johnson FK; Stark JG; Bieberdorf FA; Stauffer J
Clin Ther; 2010 Jun; 32(6):1149-64. PubMed ID: 20637968
[TBL] [Abstract][Full Text] [Related]
39. The relative potency of oral transmucosal fentanyl citrate compared with intravenous morphine in the treatment of moderate to severe postoperative pain.
Lichtor JL; Sevarino FB; Joshi GP; Busch MA; Nordbrock E; Ginsberg B
Anesth Analg; 1999 Sep; 89(3):732-8. PubMed ID: 10475315
[TBL] [Abstract][Full Text] [Related]
40. Absorption and bioavailability of oral transmucosal fentanyl citrate.
Streisand JB; Varvel JR; Stanski DR; Le Maire L; Ashburn MA; Hague BI; Tarver SD; Stanley TH
Anesthesiology; 1991 Aug; 75(2):223-9. PubMed ID: 1859010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
